Page last updated: 2024-08-21

benzoxazoles and Bronchiectasis

benzoxazoles has been researched along with Bronchiectasis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Chalmers, JD; Fernandez, C; Mange, KC; Rubino, CM; Teper, A; Usansky, H; Zou, J1
Blasi, F; Chalmers, JD; Daley, CL; Fernandez, C; Haworth, CS; Loebinger, MR; Mange, KC; Metersky, ML; O'Donnell, AE; Sibila, O; Sullivan, EJ; Zou, J1

Trials

2 trial(s) available for benzoxazoles and Bronchiectasis

ArticleYear
Pharmacokinetic/Pharmacodynamic Evaluation of the Dipeptidyl Peptidase 1 Inhibitor Brensocatib for Non-cystic Fibrosis Bronchiectasis.
    Clinical pharmacokinetics, 2022, Volume: 61, Issue:10

    Topics: Adult; Benzoxazoles; Bronchiectasis; Cathepsin G; Cystic Fibrosis; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; Fibrosis; Humans; Leukocyte Elastase; Myeloblastin; Oxazepines; Serine Proteases

2022
Phase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis.
    The New England journal of medicine, 2020, 11-26, Volume: 383, Issue:22

    Topics: Adult; Aged; Aged, 80 and over; Benzoxazoles; Bronchiectasis; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; Disease Progression; Dose-Response Relationship, Drug; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Leukocyte Elastase; Male; Middle Aged; Oxazepines; Serine Proteases; Sputum

2020